4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Philogen S.p.A. (PHIL) operates in the Biotechnology industry and is headquartered in Sovicille, Italy with about 230 employees. Its market capitalization is roughly €893 million. In the fiscal year ended 2025-12-31, PHIL reported €314M in revenue and €230M in net income.
Philogen S.p.A., a biotechnology company, engages in the research and development of drugs for oncology and chronic inflammatory diseases in Italy, Switzerland, the United States, and the European Union.
Interactive charts & full statements → Open the PHIL valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | €314M | €74M | €23M | €24M |
| Gross Profit | €309M | €71M | €20M | €21M |
| Operating Income (EBIT) | €258M | €38M | (€8M) | €1M |
| Net Income | €230M | €45M | (€6M) | (€5M) |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €437M | €168M | €119M | €126M | — |
| Total Liabilities | €64M | €30M | €29M | €28M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PHIL viewer.
About TickerBase · Data methodology & sources · Privacy · Terms